BML Health was present at the OBIO Health Science Investment Summit 2025 in Toronto addressing Regulatory Risk for MedTech companies and investors

BML Health Managing Director Marc Saab was present at the OBIO Health Science Investment Summit that took place in Toronto from February 5th to 7th, 2025. It is Canada’s Premier Health Science Investment Event bringing together leading MedTech and BioTech companies with top investors in the field. More than $1.6B has been raised by OBIO […]

Canadian Health Tech Investment took a breather in 2022. Get insights from the Pender Ventures Canadian Health Tech Funding Report 2022 Year in Review

It is no secret that 2022 was a challenging year in funding for the health tech industry, and for most industries, across global markets. After the massive runup in funding generated by the COVID induced pivot towards telehealth and the tremendous move up in financial markets it was a matter of time before markets had […]